Balance Sheet
Cash Flow Statement
Gains from Investment Securities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akso Health (AHG) Gains from Sales and Divestitures (2019 - 2022)

Akso Health (AHG) has disclosed Gains from Sales and Divestitures for 3 consecutive years, with $32234.0 as the latest value for Q1 2021.

  • For the quarter ending Q1 2021, Gains from Sales and Divestitures fell 17.14% year-over-year to $32234.0, compared with a TTM value of $32234.0 through Mar 2021, down 17.14%, and an annual FY2021 reading of $32234.0, down 17.14% over the prior year.
  • Gains from Sales and Divestitures was $32234.0 for Q1 2021 at Akso Health, down from $38900.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $538900.0 in Q1 2019 and bottomed at $32234.0 in Q1 2021.
  • Average Gains from Sales and Divestitures over 3 years is $203344.7, with a median of $38900.0 recorded in 2020.
  • The sharpest move saw Gains from Sales and Divestitures plummeted 92.78% in 2020, then dropped 17.14% in 2021.
  • Year by year, Gains from Sales and Divestitures stood at $538900.0 in 2019, then tumbled by 92.78% to $38900.0 in 2020, then decreased by 17.14% to $32234.0 in 2021.
  • Business Quant data shows Gains from Sales and Divestitures for AHG at $32234.0 in Q1 2021, $38900.0 in Q1 2020, and $538900.0 in Q1 2019.